SuperworthRocket Lab USA RKLB
- Market cap
- $31.5B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- a loss over the last year
- Price to sales
- 40.9×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $769.1M
- +53% on a year ago
- Net margin
- −21.5%
- Free cash flow yield
- −1.2%
Rocket Lab USA trades at 40.9× sales. Its trailing earnings are negative, so it has no PE. Revenue was $769.1M over the last twelve months, up 53% on a year earlier with a −22% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $67.7M+7% | $60M+16% | $92.8M+69% | $106.3M+71% | $104.8M+55% | $132.4M+121% | $122.6M+32% | $144.5M+36% | $155.1M+48% | $179.7M+36% | $200.3M+64% | $234.1M+62% | |
| Cost of revenue | $52.7M−4% | $44.5M−11% | $68.6M+41% | $79.1M+67% | $76.8M+46% | $95.6M+115% | $87.3M+27% | $98.1M+24% | $97.8M+27% | $111.4M+17% | $123.9M+42% | $149.5M+52% |
| Gross profit | $15M+77% | $15.5M+747% | $24.2M+280% | $27.2M+86% | $28M+87% | $36.8M+138% | $35.2M+46% | $46.4M+71% | $57.3M+105% | $68.2M+85% | $76.5M+117% | $84.6M+82% |
| R&D | $26.6M+52% | $37.5M+150% | $38.5M+61% | $39.9M+29% | $47.7M+79% | $48.3M+29% | $55.1M+43% | $66.1M+66% | $70.7M+48% | $78.8M+63% | $80.5M+46% | $82.4M+25% |
| SG&A | $27.2M+19% | $25.9M+8% | $28.7M+1% | $30.5M+6% | $32.2M+18% | $40.1M+55% | $39.3M+37% | $39.9M+31% | $45.6M+42% | $40.5M+1% | $51.9M+32% | $59.7M+50% |
| −$38.9M+21% | −$47.9M+29% | −$43.1M−6% | −$43.3M−4% | −$51.9M+34% | −$51.5M+8% | −$59.2M+37% | −$59.6M+38% | −$59M+14% | −$51M−1% | −$56M−5% | −$57.5M−4% | |
| Interest expense | $1.4M−5% | $1.4M+58% | $898K+31% | $824K+11% | $454K−68% | $1.8M+27% | $6.8M+657% | $7.4M+797% | $590K+30% | $20.9M+1078% | $1.3M−81% | $581K−92% |
| Pre-tax income | −$39.2M+19% | −$49.5M+30% | −$44.3M−2% | −$42.5M−6% | −$51M+30% | −$51.7M+4% | −$61.4M+39% | −$63.5M+49% | −$59.3M+16% | −$41.6M−19% | −$46.8M−24% | −$43.9M−31% |
| $1.4M−20% | $1M | $5K−99% | −$860K | $944K−30% | $675K−33% | −$813K | $2.9M | −$41.1M | $11.3M+1571% | −$1.8M+120% | $5.3M+81% | |
| Net income | −$40.6M+17% | −$50.5M+36% | −$44.3M−3% | −$41.6M−9% | −$51.9M+28% | −$52.3M+4% | −$60.6M+37% | −$66.4M+60% | −$18.3M−65% | −$52.9M+1% | −$45M−26% | −$49.3M−26% |
| −$0.08+14% | −$0.10+25% | −$0.09−10% | −$0.08−20% | −$0.10+25% | −$0.10+0% | −$0.12+33% | −$0.13+63% | −$0.03−70% | −$0.09−10% | −$0.07−42% | −$0.08−39% | |
| 484M+3% | 487M+3% | 490M+3% | 494.2M+3% | 497.7M+3% | 501.7M+3% | 505.6M+3% | 515.1M+4% | 528.7M+6% | 572.5M+14% | 605.4M+20% | 629.7M+22% |
EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY20 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $257.2M | $253.3M to $260.6M | −$0.05 | −$0.06 to −$0.03 | 6 |
| Q4 FY26 | $264.6M | $256.9M to $270.2M | −$0.05 | −$0.07 to −$0.03 | 6 |
| Q1 FY27 | $277.6M | $254.3M to $293.3M | −$0.02 | −$0.02 to −$0.02 | 2 |
| Q2 FY27 | $329.4M | $301.8M to $348M | −$0.01 | −$0.01 to −$0.01 | 2 |
| Q3 FY27 | $325.7M | $298.4M to $344.1M | −$0.01 | −$0.01 to −$0.01 | 2 |
| Q4 FY27 | $370.8M | $339.7M to $391.7M | $0.02 | $0.01 to $0.02 | 2 |
| Q1 FY28 | $350.1M | $320.8M to $369.9M | $0.03 | $0.02 to $0.03 | 5 |
| Q2 FY28 | $412.3M | $377.7M to $435.6M | $0.06 | $0.05 to $0.06 | 5 |
Peers
Companies in Aerospace & Defense nearest Rocket Lab USA's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| RKLBRocket Lab USA | $31.5B | n/m | n/a | n/m | 40.9× | +53% | −21.5% |
| AXONAxon Enterprise | $34.1B | 174× | 136× | 47.0× | 10.6× | +35% | 6.2% |
| HEIHEICO | $41.6B | 49.5× | 59.3× | 42.8× | 8.0× | +21% | 16.4% |
| LHXL3Harris Technologies | $47.3B | 25.6× | 30.1× | 20.6× | n/m | n/m | n/m |
| HONAHoneywell Aerospace | $51.8B | n/m | n/a | 20.1× | n/m | n/m | n/m |
| WWDWoodward | $17.9B | 33.8× | 31.3× | n/m | 4.3× | +22% | 13.2% |
| CWCurtiss-Wright | $17.2B | 32.0× | 23.6× | 28.8× | 4.7× | +11% | 14.8% |
| TDGTransDigm | $61.1B | 33.5× | 42.3× | 23.6× | 6.1× | +17% | 21.3% |
| FTAIFTAI Aviation | $15.9B | 33.6× | 41.7× | n/m | 5.1× | +45% | 15.9% |
| HWMHowmet Aerospace | $74.1B | 40.1× | 40.9× | 31.5× | 8.1× | +18% | 20.5% |
| TXTTextron | $13.2B | 14.5× | 17.8× | n/m | 0.9× | +9% | 6.1% |
| Peer median | $37.9B | 33.6× | 40.9× | 28.8× | 5.6× | +19% | 15.4% |
Investors who own it
Investors we follow who held Rocket Lab USA at the end of Jun 30, 2026, from their 13F filings.
- Cathie WoodARK Investment Management1.1% of portfoliotrimmed
- Baillie GiffordBaillie Gifford1.0% of portfoliotrimmed
- Polen CapitalPolen Capital0.0% of portfoliotrimmed
More on Rocket Lab USA
Each number over time
- PE ratio
- Price to sales ratio
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 62Industrial stocks with the fastest expected revenue growth
- #1of 12Aerospace and defense stocks with the fastest expected revenue growth
- #5of 46Aerospace and defense stocks with the fastest revenue growth
Its groups
About
- Industry
- Aerospace & Defense
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .